Showing results (591-600 of 977) with videos related to

Sort By:
Pageof 98
NPJ Breast Cancer|July 3, 2019
LobSig is a multigene predictor of outcome in invasive lobular carcinomaAmy E McCart Reed, Samir Lal, Jamie R Kutasovic, et al.
NPJ Breast Cancer|July 3, 2019
FGFR4 overexpression and hotspot mutations in metastatic ER+ breast cancer are enriched in the lobular subtypeKevin M Levine, Nolan Priedigkeit, Ahmed Basudan, et al.
NPJ Breast Cancer|April 10, 2019
NDRG4 promoter hypermethylation is a mechanistic biomarker associated with metastatic progression in breast cancer patientsElisa H F Jandrey, Ricardo P Moura, Luciana N S Andrade, et al.
NPJ Breast Cancer|September 6, 2018
NF1 deficiency correlates with estrogen receptor signaling and diminished survival in breast cancerPatrick S Dischinger, Elizabeth A Tovar, Curt J Essenburg, et al.
NPJ Breast Cancer|April 18, 2019
Therapeutic targeting of BRCA1 and TP53 mutant breast cancer through mutant p53 reactivationBing Na, Xin Yu, Tracy Withers, et al.
NPJ Breast Cancer|March 11, 2022
Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer modelsAnna R Michmerhuizen, Lynn M Lerner, Andrea M Pesch, et al.
NPJ Breast Cancer|March 25, 2022
Sulforaphane suppresses metastasis of triple-negative breast cancer cells by targeting the RAF/MEK/ERK pathwayYing Zhang, Qian Lu, Nan Li, et al.
NPJ Breast Cancer|April 2, 2022
Therapeutic and immunomodulatory potential of pazopanib in malignant phyllodes tumorDave Yong Xiang Ng, Zhimei Li, Elizabeth Lee, et al.
NPJ Breast Cancer|August 16, 2018
MiR-221/222 promote epithelial-mesenchymal transition by targeting Notch3 in breast cancer cell linesYuan-Ke Liang, Hao-Yu Lin, Xiao-Wei Dou, et al.
NPJ Breast Cancer|November 18, 2016
Quantitative MRI radiomics in the prediction of molecular classifications of breast cancer subtypes in the TCGA/TCIA data setHui Li, Yitan Zhu, Elizabeth S Burnside, et al.
Pageof 98